Cargando…

Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series

OBJECTIVE: The aim of the present study was to evaluate the clinical features, Hepatocellular Carcinoma (HCC) screening, treatment modalities, and Overall Survival (OS) in a series of Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma (NAFLD-HCC) Brazilian patients. METHODS: This was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alencar, Regiane Saraiva de Souza Melo, Oliveira, Claudia P., Chagas, Aline Lopes, Fonseca, Leonardo Gomes da, Maccali, Claudia, Saud, Lisa Rodrigues da Cunha, Xerfan, Mariana Pinheiro, Stefano, Jose Tadeu, Herman, Paulo, D'Albuquerque, Luiz Augusto Carneiro, Alves, Venâncio Avancini Ferreira, Carrilho, Flair Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468355/ https://www.ncbi.nlm.nih.gov/pubmed/36088887 http://dx.doi.org/10.1016/j.clinsp.2022.100097

Ejemplares similares

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
por: Kikuchi, Luciana, et al.
Publicado: (2017)

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
por: Alves, Venancio Avancini Ferreira, et al.
Publicado: (2016)

Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment
por: Da Fonseca, Leonardo G., et al.
Publicado: (2023)

Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement
por: Chagas, Aline Lopes, et al.
Publicado: (2020)

Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
por: Da Fonseca, Leonardo G., et al.
Publicado: (2022)

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
por: Chagas, Aline Lopes, et al.
Publicado: (2015)

HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST
por: NACIF, Lucas Souto, et al.
Publicado: (2018)

Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients
por: Lima, Rodrigo Vieira Costa, et al.
Publicado: (2021)

Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)
por: Carvalho, Sylene C.R., et al.
Publicado: (2021)

Cardiohepatic Interactions - from Humoral Theory to Organ Transplantation
por: Silvestre, Odilson Marcos, et al.
Publicado: (2014)

Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System
por: Kikuchi, Luciana, et al.
Publicado: (2016)

Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis
por: Nacif, Lucas S., et al.
Publicado: (2021)

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
por: Recuero, Amanda Medeiros, et al.
Publicado: (2022)

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
por: Campani, Claudia, et al.
Publicado: (2020)

249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients
por: Nogueira, Jeronimo A, et al.
Publicado: (2009)

Feasibility of SBRT for hepatocellular carcinoma in Brazil — a prospective pilot study
por: Chen, Andre Tsin Chih, et al.
Publicado: (2021)

Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
por: Da Fonseca, Leonardo G, et al.
Publicado: (2023)

NAFLD-Associated HCC: Progress and Opportunities
por: Geh, Daniel, et al.
Publicado: (2021)

Vitamin C and Vitamin E in Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in Choline Deficient Diet Fed Rats
por: Oliveira, Claudia PMS, et al.
Publicado: (2003)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review
por: Toda, Karla Sawada, et al.
Publicado: (2015)

Accuracy of transient elastography-FibroScan(®), acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
por: Ragazzo, Taisa Grotta, et al.
Publicado: (2017)

Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases
por: Herman, Paulo, et al.
Publicado: (2022)

PPARs and Mitochondrial Metabolism: From NAFLD to HCC
por: Mello, Tommaso, et al.
Publicado: (2016)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival
por: Chagas, Aline L., et al.
Publicado: (2019)

Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
por: Zitelli, Patricia Momoyo Yoshimura, et al.
Publicado: (2021)

Building an outpatient telemedicine care pilot using Scrum-like framework within a medical residency program
por: Bin, Kaio Jia, et al.
Publicado: (2021)

Technological Innovation in Outpatient Assistance for Chronic Liver Disease and Liver Transplant Patients During the Coronavirus Disease Outbreak: A Method to Minimize Transmission
por: Ono, Suzane Kioko, et al.
Publicado: (2020)

NAFLD as a risk factor for HCC: new rules of engagement?
por: Masuzaki, Ryota, et al.
Publicado: (2016)

A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
por: Eldafashi, Nardeen, et al.
Publicado: (2021)

NAFLD and MAFLD as emerging causes of HCC: A populational study
por: Myers, Shuna, et al.
Publicado: (2021)

NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
por: Fang, Jing, et al.
Publicado: (2023)

LCT‐22018G>A single nucleotide polymorphism is a better predictor of adult‐type hypolactasia/lactase persistence in Japanese‐Brazilians than LCT‐13910C>T
por: Mattar, Rejane, et al.
Publicado: (2010)

Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
por: Kim, Hyunmi, et al.
Publicado: (2021)

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
por: Longo, Miriam, et al.
Publicado: (2021)

A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes
por: Da Fonseca, Leonardo G., et al.
Publicado: (2022)

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
por: Pal Chaudhary, Surendra, et al.
Publicado: (2023)

Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
por: Nassar Junior, Antonio Paulo, et al.
Publicado: (2014)

Analysis of HFE And Non-HFE Gene Mutations in Brazilian Patients with Hemochromatosis
por: Bittencourt, Paulo Lisboa, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_q7k84am0nc7k00in007j7n9gma